For 6ghz? Yeah, not uncommon.

Is that good? Their cellular modems have been terrible. I'll reserve judgement until trying one out.

>The M1 itself is so powerful

I think this is a bit of a fallacy. Apple Silicon is great for the power consumption to power ratio, but something like a Ryzen 9 7945HX can do 3x more work than an M1 Max. And a non-laptop chip, like an Intel Core Ultra 7 265k can do 3.5x.

One comes with more easily identifying you/your network while the other comes with being more easily hacked by readily available rainbow tables (I think, but am not sure, that WPA3 fixed this, but WPA1/WPA2 use the SSID as a salt for the password)

I mean, you can't start a FaceTime call, but at least they finally let you join one.

There are sooooo many papers that prove this -- stop pretending you are too important/lazy/etc to search for them yourself because you want to write some anti-vax BS.

I 100% agree with you on the quality of information here vs. there. It is much, much more strictly moderated. But with that moderation, that subreddit does not recommend going out and getting COVID in lieu of a vaccine. Even if initial response is better for COVID.

COVID + Vaccine is by far the best, but that doesn't mean you should skip the vaccine to make sure you go the 'rona frst.

Vaccine + Vaccine (and maybe + vaccine) is, by far, the safest combination for pretty much everyone people.

You should really check what people are saying on random posts on Facebook.

100%. This strain hasn't been seen since May. It has already died out because of Delta.

All of these discussions are academic -- we really are only talking about if a Delta variant can gain these mutations and really wreck havoc. And the answer is "probably not" (for a while, anyways)

What you are saying isn't logically sound.

Those would not be in VAERS. At all.

Everyone, go get vaccinated, please.

This goes against the paper:

>A boost with mRNA-1273.351 appeared to be more effective at neutralization of the B.1.351 virus than a boost with mRNA-1273, evidenced by the higher mean GMT levels in the Part C cohort 1 participants (1400) than the GMT Part B participants (864) against the B.1.351 virus. Additionally, the difference between the wild-type and B.1.351 assays at day 1 dropped from 7.7-fold prior to the boost with mRNA-1273.351 to 2.6-fold at 15 days after the boost.

Thank you for posting this though -- I was looking for it earlier for my own comment and couldn't find it! Bookmarking now.

It should be noted that this convalescent plasma was taken from ICU patients, not people that were asymptomatic or had minor symptoms.

You are correct that it isn't proving vaccine efficacy, but it is showing a different set of antibodies created by the variant vaccines that are more effective at neutralizing the targeted variant than the antibody collection created by the original, WT-targeted vaccine.

>Side note: I hope we can do better than taking at face value investor press releases by the biopharma corps producing the vaccines.

I hate science by press release too. I wish I was better at bookmarking the pre-prints and journal articles I find/read, but they'd just be a mess I couldn't find anything in either :|

Novavax has also been working on a Beta variant booster (and I believe has moved on to a Delta booster that hasn't started NHP trials yet) -- here's some info from a presentation: https://www.novavax.com/sites/default/files/2021-05/NVAX-WVC... (It's slides 17 and 18)

Pfizer/BioNTech definitely has a Delta booster getting ready for NHP trials, but my Google Fu is lacking today, apparently.